pociredir
Modify Date: 2025-09-10 18:09:19
pociredir structure
|
Common Name | pociredir | ||
|---|---|---|---|---|
| CAS Number | 2490674-02-5 | Molecular Weight | 403.41 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C22H18FN5O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of pociredirPociredir (FTX-6058) is a potent, selective and orally active small-molecule inhibitor of embryonic ectoderm development (EED) with KD value of 0.163 nM. Pociredir (FTX-6058) can be used for the research of inflammatory or hemoglobinopathies, such as sickle cell disease (SCD) [1][2]. |
| Name | Pociredir |
|---|
| Description | Pociredir (FTX-6058) is a potent, selective and orally active small-molecule inhibitor of embryonic ectoderm development (EED) with KD value of 0.163 nM. Pociredir (FTX-6058) can be used for the research of inflammatory or hemoglobinopathies, such as sickle cell disease (SCD) [1][2]. |
|---|---|
| Related Catalog | |
| In Vivo | Pociredir (FTX-6058) (QD, 5 mg/kg) reduces the H3K27me3 levels in the Townes mouse model of sickle cell disease (SCD). Pociredir (FTX-6058) (QD, 5 mg/kg) increases the levels of red blood cells and total hemoglobin, ameliorates hemolysis in the Townes mouse model of sickle cell disease (SCD) [1]. |
| References |
| Molecular Formula | C22H18FN5O2 |
|---|---|
| Molecular Weight | 403.41 |